China Cord Blood ROE 2010-2018 | CO

Current and historical return on equity (ROE) values for China Cord Blood (CO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. China Cord Blood ROE for the three months ending September 30, 2018 was 7.53%.
China Cord Blood ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.03B $0.48B 5.62%
2018-06-30 $0.03B $0.48B 5.92%
2018-03-31 $0.04B $0.50B 8.23%
2017-12-31 $0.04B $0.47B 8.65%
2017-09-30 $0.03B $0.45B 9.13%
2017-06-30 $0.02B $0.43B 7.89%
2017-03-31 $0.02B $0.27B 6.11%
2016-12-31 $0.01B $0.26B 4.98%
2016-09-30 $0.01B $0.26B 4.94%
2016-06-30 $0.01B $0.26B 5.37%
2016-03-31 $0.01B $0.27B 5.40%
2015-12-31 $0.01B $0.26B 6.74%
2015-09-30 $0.01B $0.25B 3.93%
2015-06-30 $0.01B $0.26B 4.82%
2015-03-31 $0.01B $0.00B 7.48%
2014-12-31 $0.01B $0.00B 7.29%
2014-09-30 $0.02B $0.24B 8.03%
2014-06-30 $0.02B $0.24B 8.16%
2014-03-31 $0.02B $0.23B 8.39%
2013-12-31 $0.02B $0.23B 8.24%
2013-09-30 $0.02B $0.23B 8.15%
2013-06-30 $0.02B $0.21B 8.53%
2013-03-31 $0.02B $0.20B 8.77%
2012-12-31 $0.02B $0.19B 9.86%
2012-09-30 $0.02B $0.19B 10.53%
2012-06-30 $0.02B $0.19B 10.75%
2012-03-31 $0.02B $0.20B 11.55%
2011-12-31 $0.02B $0.18B 11.46%
2011-09-30 $0.02B $0.18B 10.64%
2011-06-30 $0.02B $0.17B 10.79%
2011-03-31 $0.01B $0.17B 9.67%
2010-12-31 $0.01B $0.16B 6.77%
2010-09-30 $0.01B $0.13B 6.57%
2010-06-30 $0.01B $0.12B 7.10%
2010-03-31 $0.01B $0.12B 9.76%
2009-12-31 $0.01B $0.12B 17.31%
Sector Industry Market Cap Revenue
Medical Medical Services $0.808B $0.149B
Global Cord Blood Corporation operates as a life sciences company. It provides umbilical cord blood stem cells from newborn babies and offers laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company also operates as cord blood banking operator. Global Cord Blood Corporation, formerly known as China Cord Blood Corporation, is based in Hong Kong, China.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.844B 24.58
PRA Health Sciences (PRAH) United States $7.421B 30.29
Charles River Laboratories (CRL) United States $6.793B 23.40
NovoCure (NVCR) Jersey $4.947B 0.00
Premier (PINC) United States $4.872B 16.51
Teladoc (TDOC) United States $4.868B 0.00
HealthEquity (HQY) United States $4.810B 94.02
AMN Healthcare Services Inc (AMN) United States $2.603B 16.88
BioTelemetry (BEAT) United States $2.584B 45.64
Medpace Holdings (MEDP) United States $2.505B 31.00
Intrexon (XON) United States $1.103B 0.00
CareDx (CDNA) United States $1.031B 0.00
Natera (NTRA) United States $1.023B 0.00
Healthways (TVTY) United States $0.861B 10.59
Apollo Medical Holdings (AMEH) United States $0.698B 0.00
Surgery Partners (SGRY) United States $0.665B 0.00
Civitas Solutions (CIVI) United States $0.643B 10.61
Establishment Labs Holdings (ESTA) $0.527B 0.00
Imprimis Pharmaceuticals (HROW) United States $0.143B 0.00
Interpace Diagnostics (IDXG) United States $0.027B 0.00
OpGen (OPGN) United States $0.012B 0.00
Cancer Genetics (CGIX) United States $0.007B 0.00
FORM Holdings (XSPA) United States $0.005B 0.00
Biocept (BIOC) United States $0.002B 0.00